Sort   by:  
 Page size 
Inhibitors of the secretion of cancer exosomes, which promote cancer progression and metastasis, can not only accelerate exosome biology research but also offer therapeutic benefits for cancer patients. We identified sulfisoxazole (SFX) which inhibits exosome secretion from breast cancer cells. SFX,...
ORGANISM(S): Homo sapiens (Human) 
2019-11-13 | PXD012689 | Pride
Expression data from sulfisoxazole-treated cancer cells
Sulfisoxazole, a FDA-approved drug, is a promising repositioned drug candidate for the treatement of various cancers. Therefore we analyzed the gene expression by microarray to identified the up-regulated and down-regulated genes after SFX treatment in both, melanoma and breast cancer cells.
ORGANISM(S): Homo sapiens 
2018-08-02 | GSE117991 | GEO
miRNA Expression data from sulfisoxazole-treated breast cancer cell-derived exosome
Sulfisoxazole, a FDA-approved drug, is a promising repositioned drug candidate for the treatement of various cancers. Therefore we analyzed the gene expression by microarray to identified the up-regulated and down-regulated genes after SFX treatment in breast cancer cell-derived exosomes.
ORGANISM(S): Homo sapiens synthetic construct 
2018-12-24 | GSE124320 | GEO
Escherichia coli strain:SW4848 Genome sequencing
Sort   by:  
 Page size